PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model

被引：0
|
作者：
Smith, Jenessa B. [1 ]
Codde, Rebecca [1 ]
Tan, Yening [1 ]
Barnett, Burton E. [1 ]
Hermanson, David [1 ]
Rengarajan, Srinivas [1 ]
Ostertag, Eric M. [1 ]
Shedlock, Devon J. [1 ]
机构：
[1] Poseida Therapeut, San Diego, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P490
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model.
    Smith, Jenessa Barbara
    Codde, Rebecca
    Tan, Yening
    Barnett, Barnett E.
    Hermanson, David
    Rengarajan, Srinivas
    Ostertag, Eric M.
    Shedlock, Devon J.
    CANCER RESEARCH, 2018, 78 (16) : 63 - 63
  • [2] First extensive preclinical evaluation of PSMA-specific tracers for prostate cancer radioligand therapy
    Ruigrok, E.
    Dalm, S. U.
    de Blois, E.
    van Vliet, N.
    van Gent, D. C.
    Haeck, J.
    de Ridder, C.
    Stuurman, D.
    Konijnenberg, M. W.
    van Weerden, W. M.
    de Jong, M.
    Nonnekens, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S156 - S156
  • [3] Dynamic SPECT imaging of PSMA-specific CAR T cells in mice bearing prostate cancer
    Emami-Shahri, Nia
    Foster, Julie
    Sosabowski, Jane
    Maher, John
    Papa, Sophie
    CANCER RESEARCH, 2016, 76
  • [4] PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
    Zuccolotto, Gaia
    Fracasso, Giulio
    Merlo, Anna
    Montagner, Isabella Monia
    Rondina, Maria
    Bobisse, Sara
    Figini, Mariangela
    Cingarlini, Sara
    Colombatti, Marco
    Zanovello, Paola
    Rosato, Antonio
    PLOS ONE, 2014, 9 (10):
  • [5] Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
    Ruigrok, Eline A. M.
    van Vliet, Nicole
    Dalm, Simone U.
    de Blois, Erik
    van Gent, Dik C.
    Haeck, Joost
    de Ridder, Corrina
    Stuurman, Debra
    Konijnenberg, Mark W.
    van Weerden, Wytske M.
    de Jong, Marion
    Nonnekens, Julie
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1339 - 1350
  • [6] ADOPTIVE TRANSFER OF PSMA-SPECIFIC, TGF-β INSENSITIVE MEMORY CD8+T CELLS: SUPPRESSION OF HUMAN PROSTATE CANCER (CAP)
    Zhang, Qiang
    Helfand, Brian
    Chen, Lin
    Qin, Weijun
    Smith, Norm
    Zhu, Julie
    Guo, Yinglu
    Lee, Chung
    JOURNAL OF UROLOGY, 2010, 183 (04): : E265 - E266
  • [7] PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
    Chen, Zhihang
    Penet, Marie-France
    Krishnamachary, Balaji
    Banerjee, Sangeeta R.
    Pomper, Martin G.
    Bhujwalla, Zaver M.
    BIOMATERIALS, 2016, 80 : 57 - 67
  • [8] Development of PSMA-specific immunotherapy for prostate cancer with PIN4 gene-modified T cells
    Papa, Sophie
    Emami-Shahri, Nia
    Liu, Zhe
    Petrausch, Ulf
    Mullen, Gregory
    Spicer, James
    Maher, John
    LANCET, 2014, 383 : 77 - 77
  • [9] Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
    Eline A. M. Ruigrok
    Nicole van Vliet
    Simone U. Dalm
    Erik de Blois
    Dik C. van Gent
    Joost Haeck
    Corrina de Ridder
    Debra Stuurman
    Mark W. Konijnenberg
    Wytske M. van Weerden
    Marion de Jong
    Julie Nonnekens
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1339 - 1350
  • [10] Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
    Zhang, Xiaokang
    Sun, Shishuo
    Miao, Yangna
    Yuan, Yifan
    Zhao, Wanxin
    Li, Hailong
    Wei, Xiaohuan
    Huang, Chao
    Hu, Xiaolei
    Wang, Bixi
    Xu, Heng
    Zhang, Wei
    Gao, Xiaoge
    Song, Jingyuan
    Zheng, Junnian
    Zhang, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) : 3511 - 3520
12345